SavedAdd your journal

Journals / Turkish Journal of Hematology / 2018 / Cilt: 35 - Sayı: 2

Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy

Takashi ONAKA
Tomoya KITAGAWA
Chika KAWAKAMI
Akihito YONEZAWA
Pages
135–136
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Özet

-

🔖

Cite This Article

ONAKA, T., KITAGAWA, T., KAWAKAMI, C., YONEZAWA, A. (2018). Improvement of Cutaneous Anaplastic Large Cell Lymphoma by Brentuximab Vedotin Monotherapy. Turkish Journal of Hematology, Cilt: 35 - Sayı: 2, 135–136. https://ajindex.com/articles/413401

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Katz J, Janik JE, Younes A. Brentuximab vedotin (SGN-35). Clin Cancer Res 2011;17:6428-6436
  2. Desai A, Telang GH, Olszewski AJ. Remission of primary cutaneous anaplastic large cell lymphoma after a brief course of brentuximab vedotin. Ann Hematol 2013;92:567-568
  3. Kaffenberger BH, Kartono Winardi F, Frederickson J, Porcu P, Wong HK. Periocular cutaneous anaplastic large cell lymphoma clearance with brentuximab vedotin. J Clin Aesthet Dermatol 2013;6:29-31.